Study Reveals Racial Disparities in Advanced HF Therapies
White adults were twice as likely as Black adults to receive a ventricular assist device or heart transplant.
Stay updated with breaking news from Left Ventricular Dysfunction. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
White adults were twice as likely as Black adults to receive a ventricular assist device or heart transplant.
A post-hoc analysis of the PARADISE-MI trial suggests relevant benefits are being missed in current trial design.
The latest recall for the company's HeartWare HVAD System involves defective batteries that could unexpectedly fail due to an electrical fault.
Monitoring of neutrophil-to-lymphocyte ratio could potentially help risk-stratify women on anthracycline chemotherapy for associated left-ventricular dysfunction, a prospective study suggests.
The novel agent most benefited those with low systolic BP, often excluded from major HF trials, but didn't help outcomes when baseline pressures were higher, post hoc analysis of GALACTIC-HF suggests.